Abstract
Background: Hypertension is a highly prevalent chronic disease worldwide and a major cardiovascular risk factor. Oleanolic acid (3β-hydroxy-olea-12-en-28-oic acid) is a widely distributed bioactive pentacyclic triterpenoid with diverse biological activities such as anti-inflammatory, hepaprotective, anti-diabetic or anti-hypertensive.
Objective: The aim of this study was to review and highlight the available data regarding the antihypertensive activity of oleanolic acid and the described mechanisms of action.
Methods: Extensive searches were made in the available literature on oleanolic acid and the data investigating its antihypertensive effects were analysed.
Results: Most of the research has been performed on animal models of hypertension, ex vivo studies with aortic ring and some in vitro tests with cell cultures, whereas clinical trials are still lacking. Treatment of hypertensive animals with oleanolic acid significantly ameliorated the rise in the systolic blood pressure. In addition, the hypotensive effects of oleanolic acid are also related to a potent diuretic-natriuretic activity and nephroprotection. In vitro studies have characterized the participation of various signalling pathways that modulate the release of vasodilation mediators.
Conclusion: In vitro and in vivo studies suggest that oleanolic acid effectively reduces blood pressure and could be an interesting co-adjuvant to conventional treatment of hypertension.
Keywords: Hypertension, cardiovascular risk, triterpenoid, vasodilation, blood pressure.
Current Molecular Pharmacology
Title:Hypotensive Effects of the Triterpene Oleanolic Acid for Cardiovascular Prevention
Volume: 14
Author(s): Antonio Sureda*, Magalida Monserrat-Mesquida, Samuel Pinya, Pere Ferriol and Silvia Tejada
Affiliation:
- Research Group on Community Nutrition and Oxidative Stress (NUCOX) and Health Research Institute of Balearic Islands (IdISBa), Department of Fundamental Biology and Health Sciences and CIBEROBN (Physiopathology of Obesity and Nutrition CB12/03/30038), University of the Balearic Islands, Palma, Illes Balears,Spain
Keywords: Hypertension, cardiovascular risk, triterpenoid, vasodilation, blood pressure.
Abstract:
Background: Hypertension is a highly prevalent chronic disease worldwide and a major cardiovascular risk factor. Oleanolic acid (3β-hydroxy-olea-12-en-28-oic acid) is a widely distributed bioactive pentacyclic triterpenoid with diverse biological activities such as anti-inflammatory, hepaprotective, anti-diabetic or anti-hypertensive.
Objective: The aim of this study was to review and highlight the available data regarding the antihypertensive activity of oleanolic acid and the described mechanisms of action.
Methods: Extensive searches were made in the available literature on oleanolic acid and the data investigating its antihypertensive effects were analysed.
Results: Most of the research has been performed on animal models of hypertension, ex vivo studies with aortic ring and some in vitro tests with cell cultures, whereas clinical trials are still lacking. Treatment of hypertensive animals with oleanolic acid significantly ameliorated the rise in the systolic blood pressure. In addition, the hypotensive effects of oleanolic acid are also related to a potent diuretic-natriuretic activity and nephroprotection. In vitro studies have characterized the participation of various signalling pathways that modulate the release of vasodilation mediators.
Conclusion: In vitro and in vivo studies suggest that oleanolic acid effectively reduces blood pressure and could be an interesting co-adjuvant to conventional treatment of hypertension.
Export Options
About this article
Cite this article as:
Sureda Antonio*, Monserrat-Mesquida Magalida, Pinya Samuel, Ferriol Pere and Tejada Silvia, Hypotensive Effects of the Triterpene Oleanolic Acid for Cardiovascular Prevention, Current Molecular Pharmacology 2021; 14 (6) : e301221189669 . https://dx.doi.org/10.2174/1874467213999201230211544
DOI https://dx.doi.org/10.2174/1874467213999201230211544 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
Call for Papers in Thematic Issues
Advances in the Diagnosis and Treatment of Head and Neck Disease
Head and neck diseases encompass a wide range of conditions affecting the oral cavity, pharynx, larynx, nasal passages, sinuses, salivary glands, and other structures of the head and neck region. These diseases can have significantly on essential function, such as breathing, swallowing, speaking, as well as the quality of life. ...read more
Common mechanisms underpinning neurodevelopmental disorders and psychiatric diseases
A growing number of large-scale epidemiologic studies has strongly suggested that common mechanisms may be shared by aberrant brain development and psychiatric disorders. There is now an appreciation of synergic roles of genetic variants and environmental stress which profoundly affect the genome integrity and reshape brain development. This can lead ...read more
Pharmacology and Toxicology of Plant Bioactive Compounds
The thematic issue "Pharmacology and Toxicology of Plant Bioactive Compounds" aims to explore the multifaceted aspects of bioactive compounds derived from plants, delving into their pharmacological properties and potential toxicological implications. This issue will encompass a wide array of research, including investigations into the therapeutic benefits of plant-derived compounds, such ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Delivery to CNS: Challenges and Opportunities with Emphasis on Biomaterials Based Drug Delivery Strategies
Current Pharmaceutical Design Side Effects of Clozapine and Some Other Psychoactive Drugs
Current Drug Safety Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis
Current Pharmaceutical Biotechnology Pharmacological and Surgical Therapy for Primary Postpartum Hemorrhage
Current Pharmaceutical Design Antihypertensive Effect of Sesamin
Vascular Disease Prevention (Discontinued) Adaptive and Compensatory Mechanisms of the Cardiovascular System and Disease Risk Factors in Young Males and Females
New Emirates Medical Journal A Walk in Nature: Sesquiterpene Lactones as Multi-Target Agents Involved in Inflammatory Pathways
Current Medicinal Chemistry Inflammatory Mediators and the Failing Heart: A Translational Approach
Current Molecular Medicine Rationalizing the Study of Plants for the Treatment of Oral Pain
Current Chemical Biology Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
Current Cancer Drug Targets Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies
Current Cancer Therapy Reviews Serum Cystatin C-A Useful Endogenous Marker of Renal Function in Intensive Care Unit Patients at Risk for or with Acute Renal Failure?
Current Medicinal Chemistry Clinical Trials for Acute Kidney Injury: Design Challenges and Possible Solutions
Current Drug Targets Small Molecules in Treatment of Sepsis
Current Drug Targets Mesoionic Oxatriazoles (MOTA): NO-Donating Characteristics and Pharmacology
Current Pharmaceutical Design Apixaban: A New Player in the Anticoagulant Class
Current Drug Targets N-substitution Reactions of 2-Aminobenzimidazoles to Access Pharmacophores
Current Organic Synthesis Ethnobotanical Survey of Medicinal Plants used to Treat Cardiovascular Disorders in Ghasemloo Valley of Urmia City
Cardiovascular & Hematological Agents in Medicinal Chemistry Current and Proposed Biomarkers of Anthracycline Cardiotoxicity in Cancer: Emerging Opportunities in Oxidative Damage and Autophagy
Current Molecular Medicine The Oxygen Therapy
Current Medicinal Chemistry